Cell-Based Therapy for Ischemic Heart Disease: A Clinical Update

Jeremy L. Herrmann, Aaron M. Abarbanell, Brent R. Weil, Yue Wang, Meijing Wang, Jiangning Tan, Daniel R. Meldrum

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Progenitor cell therapy is a promising treatment for ischemic heart disease. Early clinical trials of autologous bone marrow-derived progenitor cell therapy for acute and chronic myocardial ischemia showed modest functional improvements after cell delivery; however, the duration of these benefits remains unclear. Ongoing investigations continue to enhance our understanding of the mechanisms by which progenitor and stem cells function and how their survival and cardioprotective abilities can be improved. This review discusses: (1) relevant progenitor and stem cells in myocardial regenerative therapy, (2) routes of cell delivery to ischemic myocardium, (3) clinical trials investigating bone marrow-derived progenitor cell therapy for myocardial ischemia, and (4) future directions of the field.

Original languageEnglish
Pages (from-to)1714-1722
Number of pages9
JournalAnnals of Thoracic Surgery
Volume88
Issue number5
DOIs
StatePublished - Nov 2009

Fingerprint

Cell- and Tissue-Based Therapy
Myocardial Ischemia
Stem Cells
Bone Marrow
Clinical Trials
Myocardium
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Cell-Based Therapy for Ischemic Heart Disease : A Clinical Update. / Herrmann, Jeremy L.; Abarbanell, Aaron M.; Weil, Brent R.; Wang, Yue; Wang, Meijing; Tan, Jiangning; Meldrum, Daniel R.

In: Annals of Thoracic Surgery, Vol. 88, No. 5, 11.2009, p. 1714-1722.

Research output: Contribution to journalArticle

Herrmann, JL, Abarbanell, AM, Weil, BR, Wang, Y, Wang, M, Tan, J & Meldrum, DR 2009, 'Cell-Based Therapy for Ischemic Heart Disease: A Clinical Update', Annals of Thoracic Surgery, vol. 88, no. 5, pp. 1714-1722. https://doi.org/10.1016/j.athoracsur.2009.05.079
Herrmann, Jeremy L. ; Abarbanell, Aaron M. ; Weil, Brent R. ; Wang, Yue ; Wang, Meijing ; Tan, Jiangning ; Meldrum, Daniel R. / Cell-Based Therapy for Ischemic Heart Disease : A Clinical Update. In: Annals of Thoracic Surgery. 2009 ; Vol. 88, No. 5. pp. 1714-1722.
@article{7533ca27d5bc45c98a89ecc9e51a436e,
title = "Cell-Based Therapy for Ischemic Heart Disease: A Clinical Update",
abstract = "Progenitor cell therapy is a promising treatment for ischemic heart disease. Early clinical trials of autologous bone marrow-derived progenitor cell therapy for acute and chronic myocardial ischemia showed modest functional improvements after cell delivery; however, the duration of these benefits remains unclear. Ongoing investigations continue to enhance our understanding of the mechanisms by which progenitor and stem cells function and how their survival and cardioprotective abilities can be improved. This review discusses: (1) relevant progenitor and stem cells in myocardial regenerative therapy, (2) routes of cell delivery to ischemic myocardium, (3) clinical trials investigating bone marrow-derived progenitor cell therapy for myocardial ischemia, and (4) future directions of the field.",
author = "Herrmann, {Jeremy L.} and Abarbanell, {Aaron M.} and Weil, {Brent R.} and Yue Wang and Meijing Wang and Jiangning Tan and Meldrum, {Daniel R.}",
year = "2009",
month = "11",
doi = "10.1016/j.athoracsur.2009.05.079",
language = "English",
volume = "88",
pages = "1714--1722",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Cell-Based Therapy for Ischemic Heart Disease

T2 - A Clinical Update

AU - Herrmann, Jeremy L.

AU - Abarbanell, Aaron M.

AU - Weil, Brent R.

AU - Wang, Yue

AU - Wang, Meijing

AU - Tan, Jiangning

AU - Meldrum, Daniel R.

PY - 2009/11

Y1 - 2009/11

N2 - Progenitor cell therapy is a promising treatment for ischemic heart disease. Early clinical trials of autologous bone marrow-derived progenitor cell therapy for acute and chronic myocardial ischemia showed modest functional improvements after cell delivery; however, the duration of these benefits remains unclear. Ongoing investigations continue to enhance our understanding of the mechanisms by which progenitor and stem cells function and how their survival and cardioprotective abilities can be improved. This review discusses: (1) relevant progenitor and stem cells in myocardial regenerative therapy, (2) routes of cell delivery to ischemic myocardium, (3) clinical trials investigating bone marrow-derived progenitor cell therapy for myocardial ischemia, and (4) future directions of the field.

AB - Progenitor cell therapy is a promising treatment for ischemic heart disease. Early clinical trials of autologous bone marrow-derived progenitor cell therapy for acute and chronic myocardial ischemia showed modest functional improvements after cell delivery; however, the duration of these benefits remains unclear. Ongoing investigations continue to enhance our understanding of the mechanisms by which progenitor and stem cells function and how their survival and cardioprotective abilities can be improved. This review discusses: (1) relevant progenitor and stem cells in myocardial regenerative therapy, (2) routes of cell delivery to ischemic myocardium, (3) clinical trials investigating bone marrow-derived progenitor cell therapy for myocardial ischemia, and (4) future directions of the field.

UR - http://www.scopus.com/inward/record.url?scp=70449704532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449704532&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2009.05.079

DO - 10.1016/j.athoracsur.2009.05.079

M3 - Article

C2 - 19853156

AN - SCOPUS:70449704532

VL - 88

SP - 1714

EP - 1722

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -